# eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics, Inc. is a company headquartered in Solana Beach, CA, United States.

## Company overview

- **Legal name:** eFFECTOR Therapeutics, Inc.
- **Former names in filing history:** Locust Walk Acquisition Corp. (2020-11-04 to 2021-08-25)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Solana Beach, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001828522

## About

eFFECTOR Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001828522, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-26, it reported annual revenue of USD 0; net income of USD -35,811,000; total assets of USD 20,544,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$35.8M (USD -35,811,000)
- **Total assets:** $20.5M (USD 20,544,000)
- **Cash and equivalents:** $14.9M (USD 14,875,000)
- **Operating cash flow:** -$29.6M (USD -29,550,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $3.6M (USD 3,553,000)
- **Net income:** -$22.7M (USD -22,665,000)
- **Total assets:** $29.1M (USD 29,077,000)
- **Cash and equivalents:** $8.7M (USD 8,708,000)
- **Operating cash flow:** -$25.9M (USD -25,899,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $1.4M (USD 1,430,000)
- **Net income:** $15.8M (USD 15,798,000)
- **Total assets:** $54.1M (USD 54,056,000)
- **Cash and equivalents:** $49.7M (USD 49,702,000)
- **Operating cash flow:** -$24.9M (USD -24,888,000)

## Recent SEC filings

- Form 8-K — filed 2024-06-26 — period 2024-06-25 — 8-K
- Form 8-K — filed 2024-06-25 — period 2024-06-24 — 8-K
- Form 8-K — filed 2024-06-24 — period 2024-06-21 — 8-K
- Form 8-K — filed 2024-06-14 — period 2024-06-13 — 8-K
- Form 8-K — filed 2024-05-20 — period 2024-05-20 — 8-K
- Form 8-K — filed 2024-05-17 — period 2024-05-16 — 8-K
- Form 8-K — filed 2024-05-09 — period 2024-05-09 — 8-K
- Form 8-K — filed 2024-05-09 — period 2024-05-09 — 8-K
- Form 10-Q — filed 2024-05-09 — period 2024-03-31 — 10-Q
- Form DEF 14A — filed 2024-04-26 — period 2024-06-13 — DEF 14A
- Form 8-K — filed 2024-04-04 — period 2024-04-04 — 8-K
- Form 10-K — filed 2024-03-26 — period 2023-12-31 — 10-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/effector-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology